Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt;prévalence de l'antigène de surface de l'hépatite B et des anticorps du virus de l'hépatite C chez les donneurs de sang à Alexandrie (Égypte)

Eastern Mediterranean Health Journal

Volumn 17, Issue 3, 2011, Pages 238-242

  Wasfi, O A S ^a   Sadek, N A ^b  

^a High Institute of Public Health Egypt   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EGYPT; EMPLOYMENT STATUS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; MALE; MANUAL LABOR; SCREENING TEST; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE; URBAN RURAL DIFFERENCE; VIRUS TRANSMISSION;

EID: 79953246089     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2011.17.3.238     Document Type: Article

References (33)

1. Russmann S et al. Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: cross-sectional study. BMC Gastroenterology, 2007, 7:5.
2. Hall AJ. Control of hepatitis B by children vaccination.Reviews in Medical Microbiology, 1994, 5(2):123-130.
3. Intercountry workshop on the prevention and control of viral hepatitis. Alexandria, World Health Organization Regional Office for the Eastern Mediterranean, 1995.
4. Jafri W et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infectious Diseases, 2006, 6:101.
5. Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 2003, 52:1-33.
6. Chaudhary IA et al. Seroprevalence of Hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. Pakistan Journal of Medical Sciences, 2007, 23:64-67.
7. Elsheikh RM et al. Hepatitis B virus and hepatitis C virus in preg nant Sudanese women. Virology Journal, 2007, 4:104.
8. Vardas E et al. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Bulletin of the World Health Organization, 1999, 77:965-972.
9. Armstrong GL et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annuals of Internal Medicine, 2006, 144:705-714.
10. Feinstein AR. Principles of medical statistics, 1st ed. New York, Chapman and Hall/CRC, 2002.
11. Jekel JF, Katz DL, Elmore JG, eds. Epidemiology, biostatistics and preventive medicine, 2nd ed. Philadelphia, WB Saunders, 2001.
12. Gurol E et al. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. European Journal of Epidemiology, 2006, 21:299-305.
13. Soheir AE et al. Prevalence of anti-HIV, HBsAg and anti-HCV reactivity in different categories of Egyptian blood donors: experience of the National Cancer Institute in the last 5 years. Journal of the Egyptian National Cancer Institute, 2002, (3):217-221.
14. El-Gilany AH. El-Fedawy S. Bloodborne infections among stu14. dent voluntary blood donors in Mansoura University, Egypt. Eastern Mediterranean Health Journal, 2006, 12(6):742-748.
15. Darwish MA et al. Risk factors associated with a high sero?15. prevalence of hepatitis C virus infection in Egyptian blood donors. American Journal of Tropical Medicine and Hygiene, 1993, 49(4):440-447.
16. Acar A. HBV, HCV and HIV seroprevalence among blood do16. nors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Brazilian Journal of Infectious Diseases, 2010, 14(1):41-46
17. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/17. II infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Medical Journal, 2004, 25(1):26-33.
18. Abdel-Aziz F et al. Hepatitis C virus (HCV) infection in a com?18. munity in the Nile delta: population description and HCV prevalence. Hepatology, 2000, 32(1):111-115.
19. Arthur R et al. Hepatitis C antibody prevalence in blood donors 19. in different governorates in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91(3):271-274.
20. Sherif MM et al. Hepatitis B virus infection in upper and lower 20. Egypt. Journal of Medical Virology, 1985, 15:129-135.
21. Hasan M et al. The prevalence of HIV and hepatitis B among blood donors in Egypt. International Conference on Aids, 1993, 9:733 (abstract no. PO-C21-3098).
22. Hamidi B et al. Sero-epidemiologic survey of hepatitis B markers in national Iranian oil company (NIOC) health workers in Tehran prior to mass vaccination. Archives of Iranian Medicine, 2000, 3:4-9.
23. Baddoura R, Haddad C, Germanos M. Hepatitis B and C sero23. prevalence in the Lebanese population. Eastern Mediterranean Health Journal, 2002, 8:1-7.
24. Güven R, Ozcebe H, Cakir B. Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure. Eastern Mediterranean Health Journal, 2006, 12:749-757.
25. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis, 2004, 11:97-107.
26. Al-Faleh FZ et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. Journal of Infection, 1992, 24:197-206.
27. Nafeh MA et al. Hepatitis C in a community in Upper Egypt: 27. cross-sectional survey. American Journal of Tropical Medicine and Hygiene, 2000, 63:236-241.
28. Al-Nassiri KA, Raja'a YA. Hepatitis B infection in Yemenis in 28. Sana'a: pattern and risk factors. Eastern Mediterranean Health Journal, 2001, 7:147-152.
29. Darwish MA et al. Prevalence of HCV and HBV antibodies among intravenous drug adults and associated risk factors. Egyptian Journal of Medical Laboratory Sciences, 2005, 14.
30. El-Raziky MS et al. Prevalence and risk factors of asymptomatic 30. hepatitis C virus infection in Egyptian children. World Journal of Gastroenterology, 2007, 13:1828-1832.
31. Hepatitis C: global prevalence. Weekly Epidemiological Record, 1997, 72:341-348.
32. Mboto CI et al. Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors. British Journal of Biomedical Science, 2005, 62:89-91.
33. Bovet P et al. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bulletin of the World Health Organization, 1999, 77:923-928.